Prominent hospitals are halting gender surgeries and hormone treatments for minors
Rush Medical Center in Chicago is the latest large health system to announce that it is stopping these gender-related treatments.
The hospital's spokesperson, Tobin Klinger, confirmed to local outlets that it has "paused" hormonal therapies for new patients under 18.
Rush has not provided gender-related surgery for minors since 2023, according to Klinger.
(Adults will continue to be eligible for treatments, as will minors who were already receiving care.)
These changes follow President Donald Trump's executive order, titled "Protecting Children from Chemical and Surgical Mutilation," which was issued on January 28, 2025.
The order states that the administration will not "fund, sponsor, promote, assist or support the so-called 'transition' of a child from one sex to another," and that it will "rigorously enforce all laws that prohibit or limit these destructive and life-altering procedures."
For patients age 19 and under, "chemical and surgical mutilation" includes the use of puberty blockers, sex hormones and surgical procedures, according to the order on The White House's website.
On July 9, the Department of Justice announced that it has issued more than 20 subpoenas to doctors and clinics involved in performing "transgender medical procedures" on children.
"Medical professionals and organizations that mutilated children in the service of a warped ideology will be held accountable by this Department of Justice," Attorney General Pamela Bondi said in a statement on the DOJ's website.
Other hospitals appear to have followed actions similar to Rush Medical Center.
NewYork-Presbyterian appears to have removed and changed online verbiage for its COMPASS Program, which was previously described as a "a safe space for youth navigating their gender experience" offering "puberty suppression and gender-affirming hormone treatment."
"You don't permanently alter your body without exhausting every other option first."
The website now describes the program as "a supportive space for youth and gender," and references to gender-affirming care have been removed.
A spokesperson for NewYork-Presbyterian provided the below statement to Fox News Digital.
"We continue to work through this evolving situation to comply with applicable state and federal laws and regulations. As always, our priority is to serve all our patients in a compassionate and responsible way."
Stanford Medicine has also reportedly halted "gender-affirming surgeries," according to a statement provided to the San Francisco Chronicle.
"After careful review of the latest actions and directives from the federal government and following consultations with clinical leadership, including our multidisciplinary LGBTQ+ program and its providers, Stanford Medicine paused providing gender-related surgical procedures as part of our comprehensive range of medical services for LGBTQ+ patients under the age of 19, effective June 2, 2025," the statement said.
It was also reported that shortly after Trump's executive order, NYU Langone canceled some appointments for hormone treatments and gender surgeries, with parents claiming they were told the hospital no longer offers those services to new patients under 19.
Cleveland Clinic also responded to Fox News Digital's inquiry, confirming that the clinic "does not provide gender-affirming treatments for patients under the age of 19."
Previous studies have suggested that "gender-affirming surgeries" can be harmful to young people's mental health.
Researchers determined that rates of depression, anxiety, suicidal ideation and substance-use disorders were "significantly higher" among those with gender dysphoria who underwent surgery.
Florida neurosurgeon Dr. Brett Osborn and Jonathan Alpert, a Manhattan-based psychotherapist and author, both previously cautioned against gender-affirming surgeries for youth.
Teens who are being treated for gender dysphoria should be "properly supported and treated with compassion" without being pressured into making "life-altering" medical decisions, Alpert advised.
Osborn also stressed the need for comprehensive psychological evaluations, especially for those with preexisting mental health challenges. Mental health support, lifestyle modifications and counseling should all take precedence before surgery, not after, he said.
On July 9, the Department of Justice announced it's issued more than 20 subpoenas to doctors and clinics involved in performing "transgender medical procedures" on children.
"You don't amputate a limb because of temporary pain, and you certainly don't permanently alter your body without exhausting every other option first," he said.
Osborn expressed the same cautions about hormone therapy — "we're talking about irreversible changes that demand lifelong management."
For more Health articles, visit www.foxnews.com/health
"This isn't about politics and ideology — it's about health, longevity and making sure people don't undergo drastic, life-altering procedures only to regret them," he said.
Fox News Digital reached out to all hospitals mentioned above for comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
a minute ago
- Medscape
Unnecessary Blood Culture Testing Persists in Pediatrics
Rates of routine blood culture (BC) testing for uncomplicated infections in children had no significant effect on length of stay, costs, return emergency department visits, or hospital readmissions, according to data from nearly 95,000 hospitalizations presented at the Pediatric Hospital Medicine (PHM) 2025. Routine BC testing has shown minimal value in the clinical management of uncomplicated community-acquired pneumonia (CAP), skin and soft tissue infections (SSTI), and urinary tract infections (UTI), according to Smit K. Shah, MD, a clinical assistant professor of pediatrics at the University of Missouri-Kansas City School of Medicine, who presented the findings at the meeting. While such BC testing in an otherwise healthy pediatric population has low clinical benefit, said Shah in an interview, 'downstream harms of such testing may be leading to not just healthcare waste but patient harm.' To review the effect of BC testing patterns on outcomes, Shah and colleagues identified hospitalizations for patients aged 3 months to 18 years admitted with CAP, SSTI, or UTI from 2016 to 2023. The data on 94,524 hospitalizations across 31 hospitals came from the Pediatric Health Information System database. The researchers excluded patients with complicated infections, ICU admission, or hospital stays longer than 1 week. Hospitals were characterized as low-, moderate-, or high-BC testers (13, 10, and 8 hospitals, respectively). The primary outcomes were rates of blood culture testing by infection and hospital, annual rates of testing over 8 years, and clinical outcomes including length of hospital stay, costs, emergency department return visits, and hospital readmissions. The researchers reviewed data for 41% of CAP, 45% of SSTI, and 55% of UTI cases. BC testing rates varied widely; the widest range was from 16% to 77% for low-testing and high-testing hospitals for CAP, respectively. BC testing ranged from approximately 38% to 77% for SSTI and from approximately 22% to 77% for UTI for the low-testing and high-testing hospitals. Over the study period, seven hospitals showed significant increases, 17 showed no changes, and seven showed decreases in annual BC testing. Overall, no significant differences appeared between the high- and low-testing groups in outcome measures of adjusted length of stay, costs, emergency department return visits, hospital readmissions at 7 days, or bacteremia. The findings were limited by several factors including the use of administrative data and potential lack of generalizability to nonacademic hospitals, Shah noted. Many hospitals showed no reduction in BC testing over time, despite growing evidence of no change in outcomes, Shah said in his presentation. The results of the current study suggest that the reassessment of BC use and reduction of unnecessary testing is needed to optimize resources and improve healthcare value, Shah concluded. What Drives Disregard for Guidelines Despite guidelines from the American Academy of Pediatrics on the futility of BC testing in uncomplicated SSTIs, the proportion of hospitalized children with this infection undergoing testing is alarming and continues to remain high over time, Shah told Medscape Medical News . 'We need to understand drivers of unnecessary testing,' said Shah. Identifying whether unnecessary testing stems from institutional factors or lack of education about futility and downstream effects of unnecessary testing would help direct national stewardship efforts to reduce testing overuse, he said. 'The recent blood culture vial shortage could act as a natural experiment in reducing testing,' Shah noted 'Diagnostic stewardship in regard to blood cultures is important as overuse of blood cultures when not clinically indicated has the potential to lead to false-positive results, antibiotic overuse, antibiotic resistance, and can potentially increase healthcare costs,' said Shirin Mazumder, MD, an infectious diseases specialist in Memphis, Tennessee, in an interview. 'Evaluating scenarios where blood cultures may not be clinically indicated can help to address these issues,' said Mazumder, who was not involved in the study. The fear of missing an invasive infection and changing long-standing practice habits are some barriers to reducing unnecessary BC culture testing, but they can be overcome in part by sharing available study data, said Mazumder. In addition, the development of guidelines to determine which candidates would or would not benefit from BCs would help guide clinicians in best practices, she said. This study was supported in part by grants from the Agency for Healthcare Research and Quality to two of the coauthors. Shah reported no financial conflicts of interest.
Yahoo
43 minutes ago
- Yahoo
Trump's anti-DEI order sparks new federal funding guidance in Washington County
PORTLAND, Ore. () — Washington County has approved guidelines aimed at helping officials maintain critical funding amid President Donald Trump's anti-diversity, equity and inclusion policies. One of several established that entities with DEI practices would no longer be eligible for funding from the U.S. government. After several months of talks centered on how to preserve federal grants and other financial support, the Washington County Board of Commissioners voted to approve guiding principles during a meeting on Tuesday. CDC delves into bubonic plague case detected in Oregon in early 2024 The new guidance states that leaders will continue to operate 'in a transparent and open manner' while complying with federal, state and local regulations, among . Earlier in June, the its February 2020 commitment to DEI practices in response to the executive order. following pushback from several residents who argued leaders of the diverse county shouldn't adhere to the Trump administration's demands. However, County Administrator Tanya Ange noted that officials rely on $135 million in federal funding annually — and July through August is typically the period in which grants and contracts are renewed. Senior Medicare services administered through the Oregon Department of Human Services and overdose prevention programs managed by the Oregon Health Authority are among the resources that are currently 'at risk' as local officials wait to learn whether funding has been secured, according to Ange's . Despite uncertainty surrounding which resources will remain accessible in the county, some community members are arguing the new guidelines are too vague to ensure the protection of all residents. 'Simply changing the wording may not be enough to get the federal funds that we need, or maybe the wording is enough, but the resolution you pass is ambiguous enough to open the door for these funds to be made available for purposes they were not intended for — for not serving the under-resourced members of our community,' one testifier said. Ritz-Carlton in Portland sold back to lender to 'strengthen' struggling property District 1 Commissioner Nafisa Fai proposed an amendment that would have changed the guidelines to include language about Oregon's sanctuary state status, and to affirm that all Washington County residents would still have the right to access resources despite discrimination. When no other leaders voted to second the proposal, a decision that was met with 'boos' from attendees of the public hearing, District 4 Commissioner Jason Willey said legal counsel had already advised the county against changing the resolution. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. Solve the daily Crossword
Medscape
an hour ago
- Medscape
PCPs Guide to Prescribing Blood Thinners for AF
As a primary care physician (PCP), you're often the first healthcare professional that will identify cardiac issues, including atrial fibrillation (AF). Individuals with AF face a fivefold risk for stroke. Therefore, these patients are often prescribed blood-thinning medications (anticoagulants) to slow blood clotting, according to the American Society of Hematology (ASH). Up to six million Americans have AF, the risk for which increases with age. The ASH says there are 450,000 hospitalizations each year because of AF. It's very important to check on your patient's response within the first few months of taking blood thinners. In fact, patients with AF who took low doses of oral anticoagulants experienced a higher incidence of bleeding episodes during the first 3 months of treatment, according to a study published in Blood Advances . When Should PCPs Prescribe Anticoagulants? PCPs should consider prescribing oral anticoagulants when they are the principal caregivers for patients with AF, acute deep venous thrombosis, or acute pulmonary embolism, according to R. Michael Benitez, MD, a cardiologist at the University of Maryland Medical Center and a professor of medicine in the Division of Cardiovascular Medicine at the University of Maryland School of Medicine in Baltimore. The decision to prescribe an oral anticoagulant must be based upon the patient's risk without anticoagulation weighed in context with the patient's risk for significant bleeding, he said. How Can Physicians Best Communicate the Rationale for Anticoagulant Therapy? When describing AF, PCPs can explain to patients that the upper chamber of heart is 'wiggling' and not effectively contracting and when blood is not being effectively moved forward, it tends to clot, said Benitez. Physicians can also share that a clot as small as 2 mm is large enough to cause a major stroke if it were to break loose from the inside of the top chamber and be pumped with the blood to the brain, suggested the cardiologist. 'The oral anticoagulant greatly reduces the risk of the formation of these blood clots and subsequent stroke,' Benitez said. 'Stroke is a terrible event that, if survived, often changes a patient's life permanently and significantly. In the setting of atrial fibrillation, anticoagulation greatly reduces the patient's risk of stroke.' Regarding deep venous thrombosis, physicians can explain that a blood clot in the leg veins could break loose and be pumped through the right side of the heart to the lungs. 'This event, pulmonary embolism, can cause critical illness or even death; the risk can be greatly reduced through the use of oral anticoagulants,' said Benitez. What Are Important Directives Regarding Usage? PCPs should stress that daily use is critical to the success of the drug in preventing stroke. 'In the case of the new direct oral anticoagulants, such as apixaban or rivaroxaban, the drugs both work very quickly but also wear off very quickly,' said Benitez. 'This means that even missing just 2-3 days is enough for the blood to again clot normally. It is essential that the drugs be taken daily to prevent stroke.' In the case of warfarin, the effect of the drug is more prolonged. While missing a single dose is unlikely to markedly change the degree of anticoagulation, it's still best to remind patients not to miss doses and take this daily as prescribed, according to Benitez. What Side Effects Should Be Discussed? It is extremely important with warfarin — and to a lesser degree with direct oral anticoagulants — to always make certain that there is no drug-drug interaction that might affect the degree of anticoagulation when new medications are introduced, such as antibiotics, said Benitez. Other side effects to bring to a patients' attention are minor bleeding (such as gum bleeding with dental flossing) or nose bleeds that stop easily, which don't require immediate medical attention. However, your patients should self-monitor bleeding episodes and know a course of action if injured. 'If bleeding will not readily stop then medical attention is needed, and patients who incur major injury or trauma are likely to be taken to an emergency facility where it is important for the staff caring for them to know what anticoagulant they are taking, the dose, and when they last took it,' Benitez said. 'Reversal agents are now available to normalize blood clotting.' Your patients may be concerned with food that could interact with these medications. Benitez said there are no significant food interactions or dietary restrictions. But when prescribing warfarin, some nutritional guidance is warranted. 'With warfarin, which is a vitamin K antagonist, it is essential that the patient limit their intake of food containing vitamin K, as it is essentially an antidote or reversal agent for the anticoagulant,' he said. Some sources of vitamin K are well-known, such as leafy vegetables like spinach, kale, and other greens. However, there are many other dietary sources rich in vitamin K that may not be as obvious, such as cauliflower and soy products, Benitez said. 'It is important for the patient to familiarize themselves with vitamin K-containing foods and to keep the intake of them low and steady from day to day if they are taking warfarin,' he said.
